Literature DB >> 11568701

Interobserver and intraobserver reliability of the japanese orthopaedic association scoring system for evaluation of cervical compression myelopathy.

K Yonenobu1, K Abumi, K Nagata, E Taketomi, K Ueyama.   

Abstract

STUDY
DESIGN: The inter- and intraobserver reliabilities of an assessment scale for cervical compression myelopathy were examined statistically. This scoring system consists of seven categories: motor function of fingers, shoulder and elbow, and lower extremity; sensory function of upper extremity, trunk and lower extremity; and function of the bladder. It evaluates the severity of myelopathy by allocating points based on degree of dysfunction in each category.
OBJECTIVES: To determine the inter- and intraobserver reliabilities of the revised scoring system (17 - 2 points) for cervical compression myelopathy proposed by the Japanese Orthopedic Association. SUMMARY OF BACKGROUND DATA: Several scales to assess clinical outcome from treatment of cervical compression myelopathy have been proposed. Most of these scales include items evaluated by observers. However, no system, including the Japanese Orthopedic Association scoring system, has yet been validated in terms of interobserver reliability.
METHODS: From five different university hospitals, 10 spine surgery specialists, 10 orthopedic surgeons who had just passed the board examination of the Japanese Orthopedic Association, and 13 residents in the first or second year of orthopedic residency programs were chosen. The participants in this study were 29 patients with myelopathy secondary to ossification of the posterior longitudinal ligament selected from five participating university hospitals. Several surgeons interviewed each patient twice at intervals of 1 to 6 weeks. Inter- and intraobserver reliabilities of the total score for all categories were evaluated by the intraclass correlation coefficient. The extension of the kappa coefficient of Kraemer also was calculated for each category to assess reliability of multivariate categorical data.
RESULTS: The interobserver reliability of the total score for the first interview (intraclass correlation coefficient = 0.813) and the intra- and interobserver reliabilities of the total score (intraclass correlation coefficient = 0.826) were high. The level of experience and the hospital slightly affected the reliability of the Japanese Orthopedic Association scoring system. The kappa values for intraobserver data generally were high in each category, whereas the kappa values for interobserver data were relatively low for the categories of shoulder-elbow motor function and lower extremity sensory function.
CONCLUSIONS: The inter- and intraobserver reliabilities of the Japanese Orthopedic Association scoring system for cervical myelopathy were high, suggesting that this system is useful for assessment of cervical myelopathy in comparative studies of treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11568701     DOI: 10.1097/00007632-200109010-00014

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  126 in total

1.  Quantitative assessment of column-specific degeneration in cervical spondylotic myelopathy based on diffusion tensor tractography.

Authors:  Jiao-Long Cui; Xiang Li; Tin-Yan Chan; Kin-Cheung Mak; Keith Dip-Kei Luk; Yong Hu
Journal:  Eur Spine J       Date:  2014-08-24       Impact factor: 3.134

Review 2.  Posterior approach to the degenerative cervical spine.

Authors:  Kazuo Yonenobu; Takenori Oda
Journal:  Eur Spine J       Date:  2003-08-26       Impact factor: 3.134

3.  Chiari I malformation associated with syringomyelia: can foramen magnum decompression lead to restore cervical alignment?

Authors:  Seung Jae Hyun; Kyung Yun Moon; Ji Woong Kwon; Chang Hyun Lee; Jiha Kim; Ki-Jeong Kim; Tae Ahn Jahng; Chun Kee Chung; Hyun Jib Kim
Journal:  Eur Spine J       Date:  2013-07-04       Impact factor: 3.134

4.  Surgical treatment of multilevel cervical spondylosis in patients with or without a history of syringomyelia.

Authors:  Jörg Klekamp
Journal:  Eur Spine J       Date:  2017-02-11       Impact factor: 3.134

5.  Neck disability in patients with cervical spondylosis is associated with altered brain functional connectivity.

Authors:  Langston T Holly; Chencai Wang; Davis C Woodworth; Noriko Salamon; Benjamin M Ellingson
Journal:  J Clin Neurosci       Date:  2019-08-13       Impact factor: 1.961

Review 6.  [Spondylotic cervical myelopathy : Indication of surgical treatment].

Authors:  W Pepke; H Almansour; M Richter; M Akbar
Journal:  Orthopade       Date:  2018-06       Impact factor: 1.087

7.  Assessing structure and function of myelin in cervical spondylotic myelopathy: Evidence of demyelination.

Authors:  Hanwen Liu; Erin L MacMillian; Catherine R Jutzeler; Emil Ljungberg; Alex L MacKay; Shannon H Kolind; Burkhard Mädler; David K B Li; Marcel F Dvorak; Armin Curt; Cornelia Laule; John L K Kramer
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

8.  Diffusion tensor imaging predicts functional impairment in mild-to-moderate cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; John W Grinstead; Langston T Holly
Journal:  Spine J       Date:  2014-02-20       Impact factor: 4.166

9.  Clinical outcomes of microendoscopic decompression surgery for cervical myelopathy.

Authors:  Akihito Minamide; Munehito Yoshida; Hiroshi Yamada; Yukihiro Nakagawa; Kazuhiro Maio; Masaki Kawai; Hiroshi Iwasaki
Journal:  Eur Spine J       Date:  2009-12-03       Impact factor: 3.134

10.  Development and reliability of a standard rating system for outcome measurement of foot and ankle disorders II: interclinician and intraclinician reliability and validity of the newly established standard rating scales and Japanese Orthopaedic Association rating scale.

Authors:  Hisateru Niki; Haruhito Aoki; Suguru Inokuchi; Satoru Ozeki; Mitsuo Kinoshita; Hideji Kura; Yasuhito Tanaka; Masahiko Noguchi; Shigeharu Nomura; Masahito Hatori; Shinobu Tatsunami
Journal:  J Orthop Sci       Date:  2005-09       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.